FDA issued a Warning Letter to bioMerieux, Inc. on 8/23/2012 as a result of this inspection.
483 bioMerieux Mar 2012

483 bioMerieux Mar 2012

Claudette Brooks FDA, Paul Moy FDA, Miaja Umaedi FDA$119.00 - Available Now

FDA investigators audited the bioMerieux - Durham, NC, United States facility and issued inspectional observations (via FDA 483) on 06 Mar 2012.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 06 Mar 2012
  • Location: Durham, United States
  • FEI: 3002769706
Add To Cart